Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder

BACKGROUND: Heightened response to drug-related cues is a hallmark of addiction. Extended-release naltrexone (XR-NTX) is a US Food and Drug Administration–approved pharmacotherapy for relapse prevention in patients with opioid use disorder (OUD). In these patients, XR-NTX has been shown to reduce br...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Psychiatry Neurosci
Autors principals: Shi, Zhenhao, Wang, An-Li, Jagannathan, Kanchana, Fairchild, Victoria P., O’Brien, Charles P., Childress, Anna Rose, Langleben, Daniel D.
Format: Artigo
Idioma:Inglês
Publicat: Joule Inc. 2018
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6019353/
https://ncbi.nlm.nih.gov/pubmed/29947607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/jpn.170036
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars